<?xml version="1.0" encoding="UTF-8"?>
<p>The infectivity and rate of transmission of SARS-CoV-2 necessitates the development of an effective and operational therapeutic approach as early as possible. The CP therapy approach for COVID-19 can be implemented as an immediate therapeutic to control the disease, in the absence of appropriate drugs or vaccine. Since CP therapy has been a prevalent and effective mode of treatment in various viral infections in the past (e.g. Ebola, MERS and SARS-CoV [
 <xref rid="RSOB200174C84" ref-type="bibr">84</xref>]), the WHO is considering it for the control of COVID-19 as well. CP therapy should be explored further to make it suitable and effective in the treatment of the patients infected with SARS-CoV-2.
</p>
